Research Directory

Artificial intelligence in drug development

Read more

Long-term strategies for immuno-oncology

Read more

Novel immunotherapy arises from collaboration

Read more

A phenotypic share analysis

Read more

EU examines incentives for the pharma industry

Read more

Medigene on a new course

Read more

Using the accelerator and brake to treat cancer

Read more

The patent battle over CRISPR rages on

Read more

Working with patients to accelerate drug development

Read more

The future of RNAi in the age of gene editing

Read more